Position in BMY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,576,338,337
-$220,788,176 QoQ
Shares Held
27,357,486
-7.7% QoQ
Ownership
1.34%
of shares outstanding
% of Portfolio
0.56%
of 13F equity value
Holder Rank
#12
of 2,514 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AQR CAPITAL MANAGEMENT LLC holds $6,352,612,055 across 16 Drug Manufacturers - General names. BMY ranks #1 (24.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
This page
|
27,357,486 | $1,576,338,337 | |
| 2 | LLY |
ELI LILLY & Co
|
1,035,605 | $1,242,135,802 | |
| 3 | MRK |
Merck & Co., Inc.
|
8,134,262 | $1,045,252,665 | |
| 4 | JNJ |
Johnson & Johnson
|
2,907,803 | $738,494,723 | |
| 5 | ABBV |
AbbVie Inc.
|
2,015,238 | $507,114,486 | |
| 6 | PFE |
Pfizer Inc
|
18,557,891 | $446,874,011 | |
| 7 | BIIB |
Biogen Inc.
|
1,936,859 | $418,477,751 | |
| 8 | AMGN |
Amgen Inc
|
300,007 | $108,638,532 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,576,338,337 | 27,357,486 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $1,797,126,513 | 29,631,105 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,391,485,051 | 25,796,905 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $426,825,541 | 9,463,981 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $280,884,939 | 6,067,940 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $364,051,135 | 5,969,030 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $226,624,434 | 4,006,797 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $201,794,638 | 3,900,167 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $111,146,570 | 2,676,296 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $127,357,635 | 2,348,472 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $107,841,869 | 2,101,771 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $130,880,199 | 2,255,000 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $186,077,296 | 2,909,731 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $190,027,712 | 2,741,707 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $160,494,187 | 2,230,635 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $116,025,775 | 1,632,097 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $120,527,638 | 1,565,294 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $105,593,492 | 1,445,892 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $95,127,020 | 1,525,694 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $92,150,470 | 1,557,385 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $134,455,536 | 2,012,205 | Shares | Other | 2021-08-16 | |
| 2021-03-31 | $173,680,855 | 2,751,162 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $175,675,223 | 2,832,101 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $194,371,944 | 3,223,950 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $200,407,039 | 3,408,283 | Shares | Other | 2020-08-17 | |
| 2020-03-31 | $224,818,815 | 4,033,348 | Shares | Other | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||